Latest News and Press Releases

New Delhi, April 03, 2024 (GLOBE NEWSWIRE) -- The global circulating tumor cells market is projected to surpass the market size of US$ 19.0 billion by 2032 from US$ 9.5 billion in 2023 at a CAGR of...

New York, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The circulating tumor cells market was valued at USD 14.84 billion in 2023 with significant growth and is projected to reach USD 81.6 billion by 2033 with...

New York, Feb. 27, 2023 (GLOBE NEWSWIRE) -- The Circulating Tumor Cells (CTC) Market is projected to grow at a CAGR of 12.3% from 2023 to 2030, with a value of USD 9.85 Billion by 2030, according to...

New York, July 26, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Liquid Biopsy Market Forecast to 2027 - Covid-19 Impact and Global Analysis by Product &...

ROCKVILLE, Md., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Circulating tumor cells (CTCs) are a blistering topic of oncological conferences and research due to their tremendous potential in the area of...

Selbyville, Delaware, Dec. 01, 2021 (GLOBE NEWSWIRE) -- The liquid biopsy market size is anticipated to record a valuation of USD 10 billion by 2027, according to the most recent study by Global...

New Jersey, NJ, July 30, 2019 (GLOBE NEWSWIRE) -- Fior Markets launched a study titled, "Global Breast Cancer Liquid Biopsy Market by Circulating Biomarkers (Circulating Tumor Cells, Cell-free DNA,...

ANN ARBOR, Mich., Jan. 05, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical and health care solutions company, today announced it has entered into a...

SEATTLE, WA--(Marketwire - Dec 6, 2011) - Atossa Genetics, Inc., a health care company developing and commercializing a comprehensive set of innovative, proprietary breast health evaluation...